Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Ophthalmology | Genetic Disease

Macular Degeneration Clinical Trials

A listing of Macular Degeneration medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Age:

Gender:

Location:

Display New/Updated only

 

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Last 

Arizona

UPDATED

Gilbert Arizona 85295

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

Phoenix Arizona 85014

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

UPDATED

Phoenix Arizona 85014

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

Phoenix Arizona 85020

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

UPDATED

Phoenix Arizona 85014

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

View More ▼

UPDATED

Tucson Arizona 85710

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

UPDATED

Tucson Arizona 85704

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

UPDATED

Tucson Arizona 85750

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

UPDATED

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Gilbert Arizona 85296

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Mesa Arizona 85210

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Peoria Arizona 85381

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Peoria Arizona 85381

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Phoenix Arizona 85020

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Phoenix Arizona

A Phase 2 clinical study for patients with Macular Degeneration

Phoenix Arizona 85020

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

Phoenix Arizona 85014

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

Tucson Arizona 85704

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

Tucson Arizona 85704-5614

Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration

California

UPDATED

Bakersfield California 93309

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

Beverly Hills California 90211

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

UPDATED

Beverly Hills California 90211

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

Campbell California 95008

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

Fresno California 93720

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

View More ▼

UPDATED

Fullerton California 92835

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

UPDATED

Irvine California 92697

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

La Jolla California 92093

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

UPDATED

Loma Linda California 92354

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

UPDATED

Los Angeles California 90095

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

Mountain View California 94040

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

UPDATED

Mountain View California 94040

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

UPDATED

Oakland California 94609

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

UPDATED

Palm Desert California 92211

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

Sacramento California 95819

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

UPDATED

Sacramento California 95841

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

Sacramento California 95819

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

UPDATED

Sacramento California 95819

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

UPDATED

San Francisco California 94143

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

San Francisco California 94107

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

San Francisco California 94107

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

UPDATED

Santa Ana California 92705

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

UPDATED

Santa Barbara California 93103

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

UPDATED

Santa Barbara California 93103

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

UPDATED

Ventura California 93003

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Bakersfield California 93309

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

Bakersfield California

A clinical trial seeking patients for a research study for the treatment of Age-Related Macular Degeneration

Beverly Hills California

A clinical trial seeking patients for a research study for the treatment of Age-Related Macular Degeneration

Beverly Hills California 90211

A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.